menu

Rethinking Heart Failure

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Rethinking Heart Failure: The ACC-ECDP Recommendations on the Role of ARNIs

ReachMD Healthcare Imgae
Restart
Resume
Read full article
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    Based on the 2021 American College of Cardiology Expert Consensus Decision Pathway recommendations, it might be time to rethink our approach to heart failure. But what exactly do the latest recommendations say regarding the role of angiotensin receptor-neprilysin inhibitors (ARNis) in the treatment of heart failure with reduced ejection fraction? Joining Dr. Javed Butler to answer that key question is Dr. Nancy Albert.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    Based on the 2021 American College of Cardiology Expert Consensus Decision Pathway recommendations, it might be time to rethink our approach to heart failure. But what exactly do the latest recommendations say regarding the role of angiotensin receptor-neprilysin inhibitors (ARNis) in the treatment of heart failure with reduced ejection fraction? Joining Dr. Javed Butler to answer that key question is Dr. Nancy Albert.

Facebook Comments

Schedule18 May 2022
Webpack App